Golden Helix, Inc., a leading provider of clinical bioinformatics solutions, is pleased to announce that it has received CE mark approval for its genetic analysis platform VarSeq Suite. This significant regulatory milestone paves the way for the expansion of Golden Helix’s advanced genetic analytics products to the European market, ensuring compliance with the European Union’s health, safety, and environmental protection standards.
NIH study shows chronic wasting disease unlikely to move from animals to people
A new study of prion diseases, using a human cerebral organoid model, suggests there is a substantial species barrier preventing transmission of chronic wasting disease (CWD) from cervids—deer, elk and moose—to people.
Inimmune announces successful Phase 1 clinical results for disease modifying allergy treatment, INI-2004
Inimmune, a leading clinical stage biotech company focused on the development of novel vaccine adjuvants, immunotherapies and delivery systems, has announced the top line results from its Phase 1b Multiple Ascending Dose (MAD) study of INI-2004 in people suffering with Allergic Rhinitis.
Montana State scientists’ research on RNA editing illuminates possible lifesaving treatments for genetic diseases
A team at Montana State University published research this week that shows how RNA, the close chemical cousin to DNA, can be edited using CRISPRs. The work reveals a new process in human cells that has potential for treating a wide variety of genetic diseases.
Postdoctoral researchers Artem Nemudryi and Anna Nemudraia conducted the research alongside Blake Wiedenheft, professor in the Department of Microbiology and Cell Biology in MSU’s College of Agriculture. The paper, titled “Repair of CRISPR-guided RNA breaks enables site-specific RNA excision in human cells,” was published online Thursday in the journal Science and constitutes the latest advance in the team’s ongoing exploration of CRISPR applications for programmable genetic engineering.
The Path to a Better Tuberculosis Vaccine Runs Through Montana
A team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people than any other.
UM Research Discovers New Way to Generate Human Cartilage
University of Montana researchers and their partners have found a new method to generate human cartilage of the head and neck.
Microbion’s Topical Pravibismane Phase 1b Moderate or Severe Diabetic Foot Ulcer Infection Study is Published in International Wound Journal
Microbion Corporation today announced that the company has published results from its topical pravibismane Phase 1b study in the peer-reviewed International Wound Journal.
Vision Magazine 2024 – University of Montana Research, Innovation & Imagination
A message from Scott Whittenburg, UM Vice President for Research and Creative Scholarship:
“I’m happy to report that the research enterprise at UM continues to grow.”
Montana State sends 17 student researchers to premier national conference
Montana State University will send 17 students to one of the country’s premier celebrations of undergraduate research next week, where they will have the opportunity to present the research they have done in departments across the university. The National Conference on Undergraduate Research, or NCUR, will be held April 8-10 in Long Beach, California, and will feature undergraduate researchers from institutions nationwide.
Montana BioScience Alliance hosted Healthcare Immersion Day for Local High School Students Seeking Futures in Health-Related Fields
The Montana BioScience Alliance and industry partners are proud to announce the successful 2024 Immersion Day at Rocky Vista University and both local hospitals, the Billings Clinic and Intermountain Health, on February 23, 2024. The Immersion Day follows the Careers in Healthcare Student Summit, hosted at Montana State University Billings, on October 27, 2023.